We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
-13.9%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
–
AUM
$8.16B
AUM Growth
+$248M
Cap. Flow
+$1.5B
Cap. Flow %
18.35%
Top 10 Hldgs %
14.12%
Holding
2,786
New
644
Increased
646
Reduced
549
Closed
902

Top Buys

Rank Stock Value
1
ETR icon
Entergy
ETR
+$79.1M
2
DTE icon
DTE Energy
DTE
+$73.2M
3
FDX icon
FedEx
FDX
+$48.6M
4
MPC icon
Marathon Petroleum
MPC
+$47.5M
5
CMS icon
CMS Energy
CMS
+$45.3M

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$75.8M
2
XOM icon
ExxonMobil
XOM
+$62M
3
LIN icon
Linde
LIN
+$49.9M
4
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$38.6M
5
EXPE icon
Expedia Group
EXPE
+$29.7M

Sector Composition

Rank Sector Weight
1 Industrials 14.24%
2 Technology 13.54%
3 Utilities 9.55%
4 Financials 8.68%
5 Healthcare 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COF icon
1076
Capital One
COF
$133B
$1M 0.01%
9,619
-11,346
-54% -$1.39M
RILY icon
1077
BRC Group Holdings
RILY
$288M
$1M 0.01%
+23,723
New +$1.25M
BALY icon
1078
CALL
Bally's
BALY
$482M
$1M 0.01%
+50,300
New +$1.3M
HNST icon
1079
The Honest Company
HNST
$577M
$997K 0.01%
+341,409
New +$1.23M
PCRX icon
1080
Pacira BioSciences
PCRX
$1B
$995K 0.01%
+17,069
New +$1.12M
RVNC
1081
DELISTED
Revance Therapeutics, Inc.
RVNC
$995K 0.01%
+71,966
New +$1.11M
CPRI icon
1082
Capri Holdings
CPRI
$1.52B
$994K 0.01%
24,241
-82,467
-77% -$3.84M
REKR icon
1083
CALL
Rekor Systems
REKR
$80M
$994K 0.01%
565,000
-285,000
-34% -$813K
MIDD icon
1084
Middleby
MIDD
$5.16B
$993K 0.01%
7,921
+4,591
+138% +$663K
LMACU
1085
DELISTED
Liberty Media Acquisition Corporation Unit
LMACU
$992K 0.01%
100,000
– –
FVRR icon
1086
Fiverr
FVRR
$341M
$986K 0.01%
28,665
+15,282
+114% +$727K
SITC icon
1087
SITE Centers
SITC
$160M
$985K 0.01%
93,764
+55,276
+144% +$652K
EGO icon
1088
Eldorado Gold
EGO
$12.5B
$983K 0.01%
153,862
+72,492
+89% +$659K
TTEK icon
1089
Tetra Tech
TTEK
$9.42B
$980K 0.01%
+35,880
New +$984K
AXNX
1090
DELISTED
Axonics, Inc. Common Stock
AXNX
$980K 0.01%
+17,298
New +$948K
RVLV icon
1091
Revolve Group
RVLV
$1.66B
$978K 0.01%
37,764
-4,054
-10% -$150K
ADC icon
1092
Agree Realty
ADC
$9.25B
$975K 0.01%
13,518
-45,408
-77% -$3.15M
AMWL icon
1093
American Well
AMWL
$195M
$972K 0.01%
11,251
-6,616
-37% -$494K
CHWY icon
1094
Chewy
CHWY
$10B
$972K 0.01%
27,998
-2,796
-9% -$89.7K
BFAM icon
1095
Bright Horizons
BFAM
$3.59B
$969K 0.01%
+11,463
New +$1.14M
ESRT icon
1096
Empire State Realty Trust
ESRT
$822M
$968K 0.01%
137,683
+90,215
+190% +$733K
UNFI icon
1097
United Natural Foods
UNFI
$2.88B
$966K 0.01%
+24,523
New +$1.03M
MX icon
1098
Magnachip Semiconductor
MX
$119M
$960K 0.01%
66,086
-57,772
-47% -$993K
RAPT
1099
DELISTED
RAPT Therapeutics
RAPT
$960K 0.01%
+6,578
New +$877K
KURA icon
1100
Kura Oncology
KURA
$1.21B
$959K 0.01%
52,330
+33,540
+178% +$482K
42 43
44
45 46

Similar funds

FGP
Freestone Grove Partners San Francisco, California $15.6B AUM 27.39% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
AA
Acorns Advisers Irvine, California $15.3B AUM 18.32% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $15.8B AUM 1.29% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $15.3B AUM 24.71% 1-Year Est. Return

Michael Gelband's Q2 2022 Portfolio in Review

As of Q2 2022, Michael Gelband held 2,786 positions worth $8.16B, up 3.1% from $7.91B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Michael Gelband deployed $1.5B of net new capital in Q2 2022, opening 644 new positions and adding to 646 existing holdings. Its largest new stake was Marathon Petroleum: 508,082 shares worth $41.8M.

By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 13% a quarter earlier, followed by Technology and Utilities.

On the sell side, the largest reduction was AT&T, an estimated $75.8M trimmed.

  • Michael Gelband's largest Q2 2022 buy was Marathon Petroleum: 508,082 shares worth $41.8M.
  • Michael Gelband added most to Entergy in Q2 2022, an estimated $79.1M increase.
  • Michael Gelband's biggest Q2 2022 reduction was AT&T, cutting an estimated $75.8M.
  • Michael Gelband fully exited Linde in Q2 2022, selling an estimated $49.9M.
  • Michael Gelband's ten largest holdings make up 14% of its $8.16B portfolio in Q2 2022.
  • Michael Gelband opened 644 new positions and closed 902 in Q2 2022.
  • Michael Gelband's portfolio value rose 3.1% quarter-over-quarter to $8.16B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2022, filed 22 Aug 2022.